InspireMD to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

May 9, 2014

BOSTON, May 9, 2014 /PRNewswire/ — InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), today announced that its CEO, Alan Milinazzo, will be presenting at the Bank of America Merrill Lynch 2014 Health Care Conference at the Encore at Wynn Las Vegas. The Company will present at 12:00 p.m. PT on Thursday, May 15, 2014.

Investors unable to attend the conference may listen in to the webcast, which can be found on the Investors section of the Company’s website at www.inspire-md.com/site_en/for-investors/. The webcast will be available for 90 days following the presentation.

About InspireMD, Inc.

InspireMD seeks to utilize its proprietary MGuard(TM) with MicroNet(TM) technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.

InspireMD intends to pursue applications of this MicroNet technology in coronary, carotid (CGuard(TM)) and peripheral artery procedures. InspireMD’s common stock is quoted on the NYSE MKT under the ticker symbol NSPR.

Investor Contacts:
Todd Fromer / Garth Russell
KCSA Strategic Communications
Phone: 212-896-1215 / 212-896-1250
Email: tfromer@kcsa.com / grussell@kcsa.com

Media Contacts:
Lewis Goldberg / Samantha Wolf
KCSA Strategic Communications
Phone: 212-896-1216 / 212-896-1220
Email: lgoldberg@kcsa.com / swolf@kcsa.com

SOURCE InspireMD, Inc.

Source: PR Newswire

comments powered by Disqus